Brand India Pharma - The Responsible Healthcare Provider at CPHI Worldwide 2014

Senior officials from the Department of Commerce, along with representatives from India’s fast growing pharmaceutical industry with India Brand Equity Foundation (IBEF) would be leading the Brand India Pharma campaign at CPHI Worldwide 2014, in Paris this year. CPHI Worldwide is the largest pharmaceutical trade exhibition organised each year by the UBM Group and takes place in October rotating between three cities, namely, Frankfurt, Madrid and Paris. CPHI Worldwide 2014 is scheduled to be held 7–9 October 2014 in Paris.

The Indian presence at CPHI Worldwide 2014 will be led by Mr Rajeev Kher, Commerce Secretary, Government of India, who will be accompanied by senior officials of the Department of Commerce, the Drugs Controller General of India Dr G N Singh, State Drugs Controllers, representatives from Pharmexcil, CEO, IBEF and a large contingent of Indian business leaders from the industry.  More than 200 Indian pharmaceutical companies will be taking part in CPHI Worldwide this year as part of the Brand India Pharma initiative.

The Indian pharmaceutical industry is one of India’s greatest success stories globally and ranks amongst the top global generic formulation exporters in volume terms. Ranked the top six producers of pharmaceuticals in the world, the country has 10,500 manufacturing units and more than 3000 pharma companies.

“The Indian pharmaceutical industry has been able to penetrate highly regulated markets such as US and Europe thanks to the industry’s focus on quality and innovation. The Brand India Pharma initiative is designed to support and help our homegrown industry play a larger part on the world stage,” commented Mr Sudhanshu Pandey, Joint Secretary, Department of Commerce, Government of India.

“India’s pharma exports stood at Rs 90,000 crore (US$ 15 billion) in 2013–14. The pharma exports from India would cross the Rs 1 lakh crore (US$ 16.4 billion) in the current financial year,” added Dr P V Appaji, Director General, Pharmexcil.

The Brand India Pharma campaign is a significant initiative led IBEF under the aegis of the Department of Commerce, Ministry of Commerce and Industry, Government of India, to highlight the value proposition that Indian pharmaceuticals present today to the world.

Launched at CPHI, Japan in March 2012, the Brand India Pharma campaign has played a critical role in highlighting the value proposition of Indian pharmaceutical products in the global market. India was the Focus Country at CPHI Worldwide in 2012 and the Value Partner at Frankfurt in 2013.

“The Brand India Pharma campaign has played its part, especially at CPHI Worldwide, consistently positioning India into premium space and leveraging the platform to create create a wider, informed perspective amongst the relevant stakeholders,” said Ms Aparna Dutt Sharma, CEO, IBEF.

With a strategic mix of branding elements such as on-ground branding, media outreach, participation in business seminars and industry interactions, Brand India Pharma aims to showcase the strengths of the Indian pharmaceutical industry. This year’s campaign will focus the growth drivers within the industry (government support & regulatory framework, cost efficiencies and technical capabilities) and will play its part in reinforcing the credibility of the Indian pharmaceutical industry.